Vivek Ramaswamy

Vivek Ramaswamy

Vivek Ramaswamy (#1772)

I don't do well as a number two. I am at my best when I am leading, not following.

  • $ 2 B
  • investments
  • United States
  • M
  • 40 Years

About Me

Vivek Ramaswamy is a biotech entrepreneur, author and Republican politician who ran for president in 2024. A Harvard and Yale Law graduate, Ramaswamy began his career on Wall Street trading biotech stocks for the hedge fund QVT. In 2015, he took public a speculative Alzheimer's drug (which later failed) in a $3 billion IPO that formed the basis of Roivant Sciences, a drug discovery and investment firm. In the years since, Roivant has helped bring multiple successful drug candidates to market; positive Phase 3 trial results for brepocitinib, which targets an autoimmune disease, sent its stock soaring in late 2025. Ramaswamy left Roivant in 2020 to write Woke, Inc., a best seller, and found Strive, an asset manager that provides anti-woke investment funds. Ramaswamy helped Elon Musk found DOGE as its co-head, but departed after a few weeks amid reports of butting heads with Musk.
About Images

Achievements

Career Highlights

A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Vivek Ramaswamy’s rise and global influence.

  • #1755   Billionaires (2026)
  •   30 Under 30 - Finance (2014)

Wealth Growth

Net Worth Growth Over Time

Tracking Vivek Ramaswamy’s net worth journey over the years, highlighting key growth phases and financial milestones.

Current Net Worth: $2.4B (May 4, 2026)

© Iconic Billionaires